Editorial Board for section 'Drug Targeting and Design'
- Nanomedicine and Nanotechnology Section
- Pharmaceutical Technology, Manufacturing and Devices Section
- Physical Pharmacy and Formulation Section
- Biopharmaceutics Section
- Drug Delivery and Controlled Release Section
- Pharmacokinetics and Pharmacodynamics Section
- Gene and Cell Therapy Section
- Drug Targeting and Design Section
- Biologics and Biosimilars Section
- Clinical Pharmaceutics Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Chemistry Department, Università Statale di Milano, Via Golgi 19, I-20133 Milan, Italy
Interests: rational drug design; chemical genetics; medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Interests: rational drug design; chemical genetics; medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Faculty of Pharmacy, University of Ljubljana, Kongresni trg 12, 1000 Ljubljana, Slovenia
Interests: drug design; medicinal chemistry; molecular modelling; antibacterial agents; anticancer agents
Special Issues, Collections and Topics in MDPI journals
Interests: drug design; medicinal chemistry; molecular modelling; antibacterial agents; anticancer agents
Special Issues, Collections and Topics in MDPI journals
Nanotech Lab, Department Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
Interests: nanomedicine; pharmaceutical technology; brain delivery; cancer delivery
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; pharmaceutical technology; brain delivery; cancer delivery
Special Issues, Collections and Topics in MDPI journals
Dr. Federica Vacondio
Food and Drug Department, University of Parma, Viale delle Scienze 27/A, 43124 Parma, Italy
Interests: drug discovery; structure-property relationships; in vitro drug metabolism; lipidomics; high resolution mass spectrometry
Interests: drug discovery; structure-property relationships; in vitro drug metabolism; lipidomics; high resolution mass spectrometry
Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria, Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
Interests: bioceramics based bone grafting materials and scaffolds for regenerative biomedicine; production and study of bioceramic systems for controlled release of biotechnological and antitumoral species; nanoparticles and biocompatible matrices for biotechnological applications; silica based ordered mesoporous materials as release systems of biologically active species; cell encapsulation in silica porous materials; mesoporous materials for gene therapy and transfection; organic-inorganic hybrid materials
Special Issues, Collections and Topics in MDPI journals
Interests: bioceramics based bone grafting materials and scaffolds for regenerative biomedicine; production and study of bioceramic systems for controlled release of biotechnological and antitumoral species; nanoparticles and biocompatible matrices for biotechnological applications; silica based ordered mesoporous materials as release systems of biologically active species; cell encapsulation in silica porous materials; mesoporous materials for gene therapy and transfection; organic-inorganic hybrid materials
Special Issues, Collections and Topics in MDPI journals
1. Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing 100191, China
2. Key Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
Interests: radiolabeled probe; nuclear medicine; molecular imaging
2. Key Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
Interests: radiolabeled probe; nuclear medicine; molecular imaging
School of Life Sciences, Nanjing University, Nanjing 210093, China
Interests: chemical biology; medicinal bioinorganic chemistry; anticancer drug; anti-Alzheimer's disease drug; drug design; mechanism of action; platinum-based anticancer drug
Interests: chemical biology; medicinal bioinorganic chemistry; anticancer drug; anti-Alzheimer's disease drug; drug design; mechanism of action; platinum-based anticancer drug
Molecular Imaging & Radiochemistry, Medical Faculty Mannheim of Heidelberg University, 68167 Mannheim, Germany
Interests: radiolabeling strategies; radiotracer development; development of contrast agents for PCCT
Special Issues, Collections and Topics in MDPI journals
Interests: radiolabeling strategies; radiotracer development; development of contrast agents for PCCT
Special Issues, Collections and Topics in MDPI journals
Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada
Interests: radio-diagnosis and therapy; targeted drug delivery; nuclear medicine; radiopharmaceutical techniques
Special Issues, Collections and Topics in MDPI journals
Interests: radio-diagnosis and therapy; targeted drug delivery; nuclear medicine; radiopharmaceutical techniques
Special Issues, Collections and Topics in MDPI journals
Department of Oncology, University of Alberta, 6820 116 Street, Edmonton, AB T6G 2R3, Canada
Interests: imaging biomarkers; radiopharmaceuticals
Special Issues, Collections and Topics in MDPI journals
Interests: imaging biomarkers; radiopharmaceuticals
Special Issues, Collections and Topics in MDPI journals
School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, Hubei, China
Interests: targeted antiviral and anticancer drug discovery; diversity-oriented synthesis and rational drug design for chemical biology and drug discovery; discovery of novel SERMs, SERDs and PROTACs to improving therapeutics that target the estrogen receptor
Interests: targeted antiviral and anticancer drug discovery; diversity-oriented synthesis and rational drug design for chemical biology and drug discovery; discovery of novel SERMs, SERDs and PROTACs to improving therapeutics that target the estrogen receptor
Institute of Applied Biotechnology, University of Applied Science Biberach, 88400 Biberach, Germany
Interests: CNS drug delivery; intranasal delivery; hydrogels for mucosal delivery; antibody and protein engineering; delivery of monoclonal antibodies; safety and immune interaction; assay and model development (in vitro, ex vivo and in vivo); proof-of concept studies; mechanism-of-action studies; neurodegenerative diseases; neurobiology
Interests: CNS drug delivery; intranasal delivery; hydrogels for mucosal delivery; antibody and protein engineering; delivery of monoclonal antibodies; safety and immune interaction; assay and model development (in vitro, ex vivo and in vivo); proof-of concept studies; mechanism-of-action studies; neurodegenerative diseases; neurobiology
